Free Trial

BioXcel Therapeutics (BTAI) SEC Filings & 10K Form

$1.19
-0.01 (-0.83%)
(As of 07/23/2024 ET)

Recent BioXcel Therapeutics SEC Filings

DateFilerForm TypeView
07/17/2024
3:41 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
6:05 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
8:22 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4/A
06/18/2024
8:24 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:25 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:25 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM
BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:27 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
2:13 PM
BioXcel Therapeutics (Subject)
Rodriguez Javier (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
1:34 PM
BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
1:09 PM
BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
12:46 PM
BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
12:04 PM
BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
12:21 PM
BioXcel Therapeutics (Subject)
Steinhart Richard I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
6:00 PM
BioXcel Therapeutics (Issuer)
Bray June (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:00 PM
BioXcel Therapeutics (Issuer)
MILLER MICHAEL PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:01 PM
BioXcel Therapeutics (Issuer)
MUELLER PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:01 PM
BioXcel Therapeutics (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:02 PM
BioXcel Therapeutics (Issuer)
Votruba Michal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
7:29 PM
BioXcel LLC (Filed by)
BioXcel Therapeutics (Subject)
Form SC 13D/A
06/06/2024
7:35 PM
BioXcel Holdings, Inc. (Reporting)
BioXcel LLC (Reporting)
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
6:30 AM
BioXcel Therapeutics (Filer)
Form 424B7
05/09/2024
8:05 AM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:12 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
5:01 AM
BioXcel Therapeutics (Filer)
Form DEF 14A
04/29/2024
5:03 AM
BioXcel Therapeutics (Filer)
Form DEFA14A
04/22/2024
6:10 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
6:01 AM
BioXcel Therapeutics (Filer)
Form PRE 14A
04/10/2024
6:05 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
6:30 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
6:31 PM
BioXcel Therapeutics (Issuer)
Wiley Matthew T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
6:32 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
6:32 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
6:32 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
6:30 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
1:50 PM
BioXcel Therapeutics (Subject)
Wiley Matthew T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
1:01 PM
BioXcel Therapeutics (Subject)
Mehta Vimal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
12:20 PM
BioXcel Therapeutics (Subject)
Yocca Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
12:40 PM
BioXcel Therapeutics (Subject)
O'Neill Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The #1 Crypto for 2024 (3 Cent Coin) (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…

Click For My #1 FREE Crypto for 2024
04/03/2024
3:55 PM
BioXcel Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2024
3:05 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
6:15 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
11:45 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
7:35 AM
BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
4:27 PM
BioXcel Therapeutics (Filer)
Form 424B5
02/08/2024
6:08 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:27 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
BioXcel Therapeutics (Subject)
Form SC 13G/A
01/22/2024
11:15 PM
BioXcel Therapeutics (Filer)
Form EFFECT
12/18/2023
3:52 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:54 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:55 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:57 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:47 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
6:22 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
11:15 PM
BioXcel Therapeutics (Filer)
Form EFFECT
11/13/2023
10:59 AM
BioXcel Therapeutics (Filer)
Form RW WD
11/13/2023
9:23 AM
BioXcel Therapeutics (Filer)
Form RW
11/02/2023
5:01 AM
BioXcel Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/19/2023
3:48 PM
BioXcel Holdings, Inc. (Filed by)
BioXcel Therapeutics (Subject)
Form SC 13G/A
10/13/2023
3:01 PM
BioXcel Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/10/2023
8:09 AM
BioXcel Therapeutics (Subject)
FIL Ltd (Filed by)
Form SC 13G/A
10/10/2023
6:06 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
6:05 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
4:07 PM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
10:21 AM
BioXcel Therapeutics (Subject)
Mueller Family 2010 Irrevocable Trust (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
9:55 AM
BioXcel Therapeutics (Subject)
MUELLER PETER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
10:15 AM
BioXcel Therapeutics (Subject)
Peter Mueller 2018 Irrevocable Family Trust (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2023
7:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:47 PM
BioXcel Therapeutics (Issuer)
Mehta Vimal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:47 PM
BioXcel Therapeutics (Issuer)
O'Neill Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:48 PM
BioXcel Therapeutics (Issuer)
Rodriguez Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:49 PM
BioXcel Therapeutics (Issuer)
Steinhart Richard I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:49 PM
BioXcel Therapeutics (Issuer)
Yocca Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
6:00 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2023
6:01 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
8:11 AM
BioXcel Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2023
6:20 AM
BioXcel Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BTAI) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners